Search - tctmd.com

Displaying 21 - 40 of 67

Sort: Relevancy | Date

News Daily News

Food Insecurity Common Among Patients With ASCVD

Michael O'Riordan

August 18, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Michael O'Riordan

December 07, 2020

News Conference News AHA 2020

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

Shelley Wood

November 18, 2020

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Michael O'Riordan

April 22, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Conference News ESC 2018

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Todd Neale

August 26, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

News Daily News

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

Michael O'Riordan

June 18, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

Proximity to Physical Activity Facilities May Play Role in Body Fat Levels

Michael O'Riordan

December 13, 2017

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

News Conference News ESC 2017

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Michael O'Riordan

August 29, 2017

Advertisement

Food Insecurity Common Among Patients With ASCVD

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD

Obesity Worsens Outcomes in COVID-19, Especially for Younger Adults

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Microvascular Disease Quadruples Risk of Leg Amputation

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

ASCEND: Aspirin Doesn’t Look Good for Primary CV Prevention in Diabetic Patients

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Proximity to Physical Activity Facilities May Play Role in Body Fat Levels

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Anacetrapib Finds (Modest) Success Where All Other CETP Inhibitors Failed

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content